Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

12results about How to "Improve mitochondrial function" patented technology

A composition containing milk thistle extract and 1,6-diphosphate fructose and its application in liver protection, sobering up and anti-fatigue

The invention discloses a composition, which contains milk thistle extract and fructose 1,6-diphosphate or its derivatives or salts thereof; the milk thistle extract is in the form of milk thistle extract microcapsules and / or milk thistle extract liposomes and / or milk thistle extract self-microemulsification forms; the composition of the milk thistle extract and FDP has the effects of reducing liver damage, preventing hangover and resisting fatigue, and is particularly capable of quickly taking effect to reduce liver damage and quickly sobering up.
Owner:NANJING AURORA BOREALIS BIOTECHNOLOGY CO LTD

Application of urolithin A in Alzheimer's disease

The invention provides application of urolithin A in Alzheimer's disease, belongs to the technical field of medicinal chemistry and treatment of mental diseases, and aims to solve the problem of social anxiety caused by the Alzheimer's disease. According to the application disclosed by the invention, the mitochondrial autophagy effect of urolithin A is utilized, A beta is eliminated, a key brain region loop aBLA-vCA1 is repaired, and the anxiety symptom of a patient suffering from the Alzheimer's disease is relieved. According to the present invention, with the application of the urolithin A in the treatment of Alzheimer's disease, through the mitochondrial autophagy function of the urolithin A, the targeted removal of A beta and the repair of the damaged basal outer side amygdala nucleus and hippocampus loop are achieved so as to effectively relieve the anxiety symptom of the patient and provide the new strategy for the AD treatment.
Owner:SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION (SHENZHEN HEALTH INSPECTION CENTER SHENZHEN INSTITUTE OF PREVENTIVE MEDICINE)

New medical application of icariin

PendingCN119139333AImprove mitochondrial functionpromote proliferationOrganic active ingredientsSexual disorderDiseaseGranular cell
The invention relates to application of icariin in preparation of a medicine for treating ovarian reserve function decline diseases. The ovarian reserve function decline disease is infertility caused by ovarian reserve function decline. It is found through experiments that icariin improves the number of DOR mouse sinus follicles; the effect of icariin on the hormone level of a DOR mouse; the influence of icariin on DOR mouse ovarian apoptosis; the influence of icariin on the ovary mitochondrial function of the DOR mouse; icariin (ICA) can be used for increasing the proliferation of ovarian granular cells induced by CTX; icariin can improve the mitochondrial function; the icariin can improve the mitochondrial membrane potential and reduce the generation of active oxygen. The traditional Chinese medicine monomer icariin has a considerable clinical application prospect in improvement of mouse ovarian reserve function decline.
Owner:YUEYANG INTEGRATED TRADITIONAL CHINESE & WESTERN MEDICINE HOSPITAL SHANGHAI UNIV OF CHINESE TRADITIONAL MEDICINE

SiRNA for inhibiting expression of BNIP3L protein and application of siRNA in preparation of medicine for resisting myocardial cell hypoxia injury

The invention belongs to the technical field of biology, and discloses siRNA for inhibiting BNIP3L protein expression and application of the siRNA in preparation of a medicine for resisting myocardial cell hypoxia injury. The siRNA for inhibiting BNIP3L protein expression is composed of a positive-sense strand and an antisense strand, the nucleotide sequence of the positive-sense strand is as shown in SEQ ID No. 1, and the nucleotide sequence of the antisense strand is as shown in SEQ ID No. 2. The siRNA for inhibiting the expression of the BNIP3L protein can obviously inhibit the expression of the BNIP3L of myocardial cells H9c2, down-regulate the autophagy level of mitochondria and obviously enhance the cell activity and mitochondrial function of the myocardial cells under hypoxia, and has the effect of resisting hypoxia-induced myocardial injury.
Owner:ENERGY SAVING & ENVIRONMENTAL PROTECTION & OCCUPATIONAL SAFETY & HEALTH RES INST OF CHINA ACAD OF RAILWAY SCI CORP LTD +2

A nano-enzyme material, a preparation method and application thereof

The application belongs to the technical field of biological nanomaterials, and particularly relates to a nano-enzyme material and a preparation method and application thereof. The application reacts dimethyl imidazole and metal salt in an aqueous solution to obtain a metal-dimethyl imidazole composite material solution, wherein the metal salt comprises copper salt and / or zinc salt; and reacts the metal-dimethyl imidazole composite material solution and tannic acid to obtain a nano-enzyme material. The nano-enzyme material provided by the application has excellent antioxidant enzyme-like catalytic activity and good biocompatibility, can effectively remove abnormally increased reactive oxygen species (ROS) in the process of myocardial infarction and myocardial ischemia-reperfusion injury, inhibit inflammatory response and myocardial cell apoptosis, improve the mitochondrial function state, thereby promoting the repair of damaged myocardial tissue and significantly improving the cardiac function, and provides a new technical solution for the treatment of myocardial infarction and related ischemic cardiovascular diseases.
Owner:SHANXI MEDICAL UNIV

Spermidine composition for inhibiting aging of hair follicle stem cells and promoting growth period and application

The invention discloses a spermidine composition for inhibiting aging of hair follicle stem cells and promoting growth period entry and application, and relates to the technical field of biological medicine and functional skin care. The invention discloses a spermidine composition for inhibiting aging of hair follicle stem cells and promoting growth period entry. The skin care product is prepared from the following components in parts by mass: 0.5 to 3 parts of spermidine, 0.2 to 2 parts of an autophagy activator, 0.5 to 4 parts of an antioxidant, 0.1 to 2 parts of a mitochondrial function accelerant, 0.2 to 3 parts of a microcirculation accelerant, 1 to 6 parts of a skin penetration accelerant, 0.2 to 1 part of a preservative, 0.05 to 0.4 part of a pH regulator and 60 to 95 parts of a carrier matrix. The composition can effectively reduce the aging rate of hair follicle stem cells and remarkably improve the proliferation activity of the hair follicle stem cells, active oxygen free radicals around the hair follicle stem cells can be effectively removed by adding the antioxidant of a novel structure, damage of external stimulation to hair follicles is reduced, and a systematic cell protection and repair mechanism is formed.
Owner:SHANGHAI ERGOTEIN BIOTECHNOLOGY GRP CO LTD

Application of microorganism-derived outer membrane vesicles in medicines for treating obesity and related metabolic diseases

The invention relates to application of microorganism-derived outer membrane vesicles in medicines for treating obesity and related metabolic diseases, and belongs to the technical field of exosomes. In order to solve the technical problems that probiotics beneficial to intestinal tracts are weak in colonization ability in the intestinal tracts, are easily influenced by gastrointestinal tract environments and are unstable in individual response, the sphingosine-containing microbe-sourced outer membrane vesicle is provided, and the sphingosine content in the outer membrane vesicle is 50-65 ng / mg.
Owner:SUN YAT SEN UNIVERSITY SHENZHEN +1

Application of cell endogenous metabolite in preparation of medicine for treating and / or preventing senescence

ActiveCN119318660Areturn to normal growthImprove mitochondrial functionOrganic active ingredientsAntinoxious agentsEndogenous metabolismPremature aging
The invention discloses an application of a cell endogenous metabolite in preparation of a medicine for treating and / or preventing senescence. The cell endogenous metabolite is any one or a combination of more of phosphocreatine, hypotaurine and / or ethanolamine phosphate. The invention finds that phosphocreatine, hypotaurine and phosphoethanolamine can effectively recover cell growth, reduce SA-beta-Gal staining intensity of cells, improve mitochondrial functions of the cells, increase ATP yield, recover mitochondrial membrane potential of the cells and relieve damage and premature aging caused by oxidative stress of the cells under a specific concentration. The life of the nematodes can be prolonged; the exercise ability in the aging middle stage is recovered. Meanwhile, the three metabolites have a synergistic effect, and the same cell protection effect can be achieved by adjusting the proportioning concentration of the three metabolites and performing mixed administration. The endogenous metabolites have the characteristics of accuracy, high efficiency and safety at the same time, so that the three cell endogenous metabolites provided by the invention can be used for preparing anti-aging drugs.
Owner:UNIV OF SCI & TECH OF CHINA

Composition acting on ovary somatic cell membrane structure and application thereof

PendingCN121846245AImprove ovarian functionImprove mitochondrial functionPeptide/protein ingredientsSexual disorderBiotechnologyCell membrane
The invention discloses a composition acting on an ovary somatic cell membrane structure and application of the composition. The composition acting on the ovary somatic cell membrane structure comprises the following components in parts by weight: 12-18 parts of a clove extract, 4-8 parts of a sophora flower bud extract, 8-12 parts of Chinese yam protein polypeptide, 4-8 parts of a cranberry extract and 8-12 parts of a citrus extract. The composition can act on an ovary somatic cell membrane structure to improve the mitochondrial function of oocytes, increase the number of the oocytes and reduce the fragment rate of the oocytes, so that the ovary function of elderly women is improved, and the purposes of improving the fertility and delaying senescence are achieved.
Owner:HAINAN LEYUN BIOTECHNOLOGY CO LTD

Mixed gas as well as preparation method and application thereof

PendingCN119235907AImprove mitochondrial functionStable in natureNervous disorderInorganic active ingredientsHippocampal regionCentral neuron
The invention belongs to the technical field of antidepressant drugs, and particularly relates to mixed gas as well as a preparation method and application thereof. The invention provides a mixed gas which comprises hydrogen, oxygen and nitrogen, the volume concentration of the hydrogen is 2%-3%, the volume concentration of the oxygen is 21%, and the volume concentration of the nitrogen is 76%-77%. After the mixed gas disclosed by the invention is inhaled, the gas capable of penetrating through the blood brain barrier directly reaches central nervous unit cells, so that the mixed gas takes effect quickly; in addition, the hydrogen, the oxygen and the nitrogen in the mixed gas are wide in preparation source, low in cost, free of side effects on organisms, high in safety and free of influence on daily activities. The mixed gas can improve the mitochondrial function, improve neuron damage of the hippocampus and effectively prevent the progress of depression.
Owner:INST OF BASIC THEORY OF TCM CHINA ACADEMY OF CHINESE MEDICAL SCI

Mitochondrial function-improving composition

PendingEP4166149A4Improve mitochondrial functionreduce inflammationPowder deliveryDispersion delivery
A problem is to provide an active ingredient which can improve mitochondrial function. Another problem is to provide a composition for suppressing myositis or muscular atrophy. One, two or more kinds selected from a bacterium of the genus Akkermansia, a culture of the bacterium and a treated product of the bacterium are used as an active ingredient of a mitochondrial function-improving composition. The composition can be preferably applied to use for suppressing myositis or suppressing muscular atrophy.
Owner:MORINAGA MILK IND CO LTD

Application of limonin in preparation of medicine for improving renal fibrosis

The invention belongs to the technical field of biological medicines, and particularly relates to application of limonin in preparation of a medicine for improving renal fibrosis. The limonin used in the invention is also named evodia lactone, the CAS number of the limonin is 1180-71-8, the molecular formula of the limonin is C26H30O8, and the structure of the limonin compound is as shown in the formula I. The limonin compound can be applied to the field of pharmaceutical chemistry. According to the application, a unilateral ureteral obstruction model is constructed, a positive drug captopril is taken as a control group, and the application of limonin in improvement of renal fibrosis caused by acute kidney injury is verified. Results of embodiments show that limonin not only has low cytotoxicity and high safety, but also has anti-inflammatory and anti-fibrosis effects, and can inhibit proliferation and migration of renal fibroblasts and improve mitochondrial functions of renal epithelial cells.
Owner:SOUTHWEST MEDICAL UNIV